Anna Podolanczuk, M.D., M.S., discusses how key epidemiological trends in idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF), including changes in incidence and prevalence, ...
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Take a look at the best performing print articles of 2024. This year's top article spotlights the surge of mRNA vaccines ...
Gene therapies are revolutionizing treatment for hemophilia A and sickle cell disease; however, they are saddled with hefty ...
Liraglutide injection is now approved for adult and pediatric patients ages 10 and up, proving another option amid the GLP-1 ...
Up to half of obstructive sleep apnea patients taking Zepbound had no symptoms after one year of treatment, averaging 25 ...
Historically, healthcare organizations have considered the contact center to be a cost center, a communications platform for ...
The FDA recently approved the treatment by Novo Nordisk for hemophilia A or B with inhibitors, designed to prevent or reduce ...
The boxed warning follows a safety warning the FDA issued in September about the risk of liver injury from the use of Veozah ...
A new bill in Congress would require pass-through prices in both Medicare, and Medicaid and require transparency of PBM ...
Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...
The temporary spending bill that the House and Senate approved last night will keep the federal government operating through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback